During the trial, the claimant's attorneys presented e-mails showing that Bard officials knew the material used to make the company's Avaulta mesh, which the company pulled off the market last year, was unfit for implantation in humans.
Several vaginal mesh manufacturers are facing scores of claims over injuries allegedly caused by the material, which doctors use to treat women with pelvic organ prolapse and incontinence. Bard alone still faces more than 8,000 other claims over its vaginal mesh devices.